Results 141 to 150 of about 243,088 (257)
Influenza A virus hemagglutinin (HA); influenza B HA [PDF]
openaire +1 more source
High‐grade serous ovarian carcinoma (HGSOC) is plagued by platinum resistance, with malignant ascites closely linked to poor outcomes. Here, we identify ASCOR, a circRNA enriched in ascites small extracellular vesicles (sEVs) from platinum‐resistant HGSOC patients, as a predictor of poor survival. ASCOR enhances platinum resistance in vitro and in vivo
Hanyuan Liu +10 more
wiley +1 more source
N-glycosylation at the receptor binding site drives differences in receptor binding specificity between influenza B virus lineages. [PDF]
Page CK +11 more
europepmc +1 more source
Existing Evidence for Influenza B Virus Adaptations to Drive Replication in Humans as the Primary Host. [PDF]
Pekarek MJ, Weaver EA.
europepmc +1 more source
This review examines emerging combination immunotherapy strategies tailored to distinct tumor microenvironments and highlights next‐generation biomarkers that guide response prediction and treatment personalization. It integrates lessons from unsuccessful trials, addresses toxicity challenges, and outlines approaches for early biomarker discovery and ...
Asmita Pandey +6 more
wiley +1 more source
Sulfatide Binds to Influenza B Virus and Enhances Viral Replication. [PDF]
Kurebayashi Y +7 more
europepmc +1 more source
Constitutive PRKCN expression is driven by super‐enhancers and modulated by NF‐κB signaling in multiple myeloma (MM). PRKCN activates mTORC1/2‐IRF4 signaling axis and favors tumor cell growth independently of its kinase activity. IRF4 reciprocally promotes PRKCN transcription, creating a feed‐forward loop.
Koukou Tang +12 more
wiley +1 more source
One-Step RAA and CRISPR-Cas13a Method for Detecting Influenza B Virus. [PDF]
Zhang X +10 more
europepmc +1 more source
This study investigates the impact of various post‐processing methods (filtration, sonication, dialysis, and heating) on lipid nanoparticles produced using microfluidics. The nanoparticles are designed for efficient delivery of miRNA into cells. The work highlights how processing conditions influence nanoparticle stability and quality, providing ...
Alicja Kosik‐Kozioł +8 more
wiley +1 more source
Characterisation of an influenza B virus-derived peptide presented by HLA-B*18:01. [PDF]
Murdolo LD +6 more
europepmc +1 more source

